Oceanside, CA, United States of America

Timothy A Vickers

This inventor holds 23 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Gene Expression Modulation. Top assignees: Isis Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Regulus Therapeutics Inc.. Active years: 1997-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy A Vickers. Retrieved from https://idiyas.com/inventor/timothy-a-vickers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 69.6


Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 771(Granted Patents)


Location History:

  • Vista, CA (US) (1999 - 2002)
  • Oceanside, CA (US) (1997 - 2017)
  • Oceaside, CA (US) (2018)

Company Filing History:


Years Active: 1997-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Expression
Oligonucleotides
RNA Mimicry
Epigenetic Control
B7 Protein
Telomere Length
miR-33 Inhibition
MYD88 Splicing
Oligomeric Compounds
Chemically-Synthesized
Antisense Modulation
Synthetic Unrandomization
23 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy A. Vickers in Biotechnology

Introduction: Timothy A. Vickers, based in Oceanside, California, is a notable inventor with a remarkable portfolio of 23 patents. His work primarily focuses on advancements in biotechnology, particularly in the modulation of gene expression and epigenetic control. Vickers has made significant contributions that have the potential to influence medical treatments for various diseases and disorders.

Latest Patents: Among his recent patent filings, Timothy Vickers has made strides with his work titled "Compositions and methods for modulation of LMNA expression." This patent describes compounds, compositions, and methods aimed at altering the expression of the LMNA gene in cells, tissues, or animals. Additionally, it includes innovative methods for target validation and suggests the potential use of these compositions in creating medicaments for treating related diseases.

Another noteworthy patent focuses on the "Regulation of epigenetic control of gene expression." This patent presents methods for identifying compounds that selectively influence epigenetic alterations in gene expression. It offers a variety of compounds, compositions, kits, assays devices, and methods for modulating small non-coding RNAs, which play a crucial role in epigenetic regulation within heterochromatic regions.

Career Highlights: Timothy Vickers has been associated with several reputable companies in the biotechnology sector. Notably, he worked at Isis Pharmaceuticals, Inc. and Regulus Therapeutics Inc., where he contributed to groundbreaking research and innovative solutions in drug development. His extensive work and dedication have significantly impacted the biotechnology field.

Collaborations: Throughout his career, Vickers has collaborated with prominent scientists including David J. Ecker and C. Frank Bennett. These collaborations have further enhanced his research capabilities and have led to numerous successful innovations in genetics and drug development.

Conclusion: Timothy A. Vickers stands out as an accomplished inventor in the biotechnology landscape, with a strong focus on gene expression modulation and epigenetic regulation. His extensive patent portfolio and collaborations with distinguished researchers underscore his commitment to advancing the field of medical science. As the landscape of biotechnology continues to evolve, Vickers' contributions are likely to play a pivotal role in the development of new therapies and medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…